drugset / Trial / NCT01336166
The Long-term Immunogenicity of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 Vaccine
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The aim of this study is to investigate the long-term immunogenicity and safety of the inactivated split-virion vaccine after one immunization.
Timeline
- Start
- 2009-07
- Primary completion
- 2011-07
- Completion
- 2011-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | split-virion, non-adjuvanted H1N1 vaccine | Vaccine | 15 ug | — |
| Subject | split-virion, non-adjuvanted H1N1 vaccine | Vaccine | 30 ug | — |
| Subject | split-virion, non-adjuvanted H1N1 vaccine | Vaccine | 45 ug | — |